U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
South Korea Forms Major AI Infrastructure Alliance with Nvidia Chips
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Trump Pardons Former Honduran President Juan Orlando Hernández in Controversial Move
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup 



